Matricellular protein CCN3 in vascular homeostasis
基质细胞蛋白 CCN3 在血管稳态中的作用
基本信息
- 批准号:10504077
- 负责人:
- 金额:$ 67.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-15 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAngiotensin IIAnimalsAnti-Inflammatory AgentsAortaAortic AneurysmAtlasesAutomobile DrivingBehaviorBiochemicalBlood VesselsCellsChestCommunicationDevelopmentDilatation - actionDissectionEndothelial CellsEndotheliumEnvironmental Risk FactorEventExhibitsExposure toExtracellular Matrix DegradationFoundationsFunctional disorderGene FamilyGleanHealthHistologicHomeostasisIn VitroIncidenceInfiltrationInflammasomeInflammationInfusion proceduresKnockout MiceKnowledgeLaboratoriesLeadLeftLeukocytesMaintenanceMarfan SyndromeMedicalModelingMolecularMorbidity - disease rateMusMutationOperative Surgical ProceduresOrganOxidative StressPathogenesisPathologicPharmacologyPhysiologicalPhysiologyPlant RootsPlayPreventionPropertyProteinsReactive Oxygen SpeciesRegulationResearchRoleRuptureSecondary toSeveritiesSignal PathwayTherapeuticThoracic Aortic AneurysmTissuesVascular DiseasesVascular EndotheliumWorkcell typeconditional knockoutendothelial dysfunctionexperimental studygene networkin vivoinhibitorinsightmembermortalitymouse modelnovelnovel therapeutic interventionnovel therapeuticspreventsingle-cell RNA sequencingtranscriptome sequencingvascular inflammation
项目摘要
SUMMARY
Aortic homeostasis is essential for vascular health. The vascular endothelium is a vital organ whose health is
essential to normal vascular physiology; when dysregulated, it becomes a critical factor in the pathogenesis
of a variety of vascular diseases. Growing evidence indicates that endothelial cells (ECs) play an
underappreciated role in the development and progression of thoracic aortic aneurysm and dissection (TAAD).
Most notably, compromised barrier integrity has been implicated as a precursor to the development of TAA.
Work from our laboratory has led to the appreciation that a member of Cellular Communication Network (CCN)
gene family, CCN3, serves as an important regulator of vascular health. However, the precise physiological
role of CCN3 in vivo as well as the fundamental mechanisms responsible for CCN3’s action remain largely
undefined. Recently, our preliminary studies suggest that CCN3 serves as an endogenous inhibitor of TAAD.
Recently, our preliminary studies suggest that endothelial dysfunction due to CCN3 deficiency predisposes
animals to thoracic aortic aneurysm and dissection (TAAD). In a mouse model of Marfan syndrome
(Fbn1mgR/mgR), global deficiency of CCN3 deficiency exacerbates thoracic aortic aneurysm (TAA) in Marfan
mice characterized by increased aortic root and ascending thoracic aortic dilation, elevated incidence of
vessel dissection, and, as a consequence, enhanced mortality. Similar findings were obtained when
challenging animals with angiotensin II (Ang II). Endothelial restricted knockout mice (EC CCN3-/-)
subjected to Ang II infusion exhibited augmented aortic root and thoracic aortic dilation along with an elevated
severity of aortic wall destruction. Mechanistically, our initial bulk RNAseq studies suggested that loss of
CCN3 perturbs vascular junction and causes aberrant activation of signaling pathways involved in
inflammation. Our subsequent in vivo and in vitro studies further support that key factors secondary to CCN3
deficiency (endothelial barrier disruption, inflammation, reactive oxygen species (ROS)) cause endothelial
dysfunction and play a pivotal role in TAAD development and progression. These observations provide the
foundation for the central hypotheses of this application: CCN3 serves as a critical physiological regulator for
the maintenance of endothelial function essential for the prevention of TAAD. Studies in this proposal will
rigorously address this hypothesis. The role of endothelial CCN3 in mitigating TAAD will be fully characterized.
Mechanistic basis of how CCN3 deficiency leads to endothelial dysfunction will be investigated. The results
of these studies will elucidate the role of CCN3 in controlling endothelial function and the mechanisms
underlying its ability to promote endothelial barrier integrity and limit inflammation.
概括
主动脉稳态对于血管健康至关重要 血管内皮是一个重要的器官,其健康状况至关重要。
对正常血管生理至关重要;当失调时,它成为发病机制的关键因素
越来越多的证据表明内皮细胞(EC)在多种血管疾病中发挥着重要作用。
在胸主动脉瘤和夹层(TAAD)的发生和进展中的作用未被充分认识。
最值得注意的是,屏障完整性受损被认为是 TAA 发展的先兆。
我们实验室的工作引起了蜂窝通信网络 (CCN) 成员的赞赏
基因家族 CCN3 是血管健康的重要调节因子,但其精确的生理功能却受到影响。
CCN3 在体内的作用以及负责 CCN3 作用的基本机制在很大程度上仍然存在
最近,我们的初步研究表明 CCN3 是 TAAD 的内源性抑制剂。
最近,我们的初步研究表明,CCN3 缺乏导致的内皮功能障碍容易导致
在马凡综合征小鼠模型中,动物出现胸主动脉瘤和夹层(TAAD)。
(Fbn1mgR/mgR),CCN3 的整体缺乏会加剧马凡的胸主动脉瘤 (TAA)
以主动脉根部增加和升胸主动脉扩张为特征的小鼠,发生率升高
血管解剖,因此,死亡率增加时也得到了类似的结果。
用血管紧张素 II (Ang II) 挑战动物 (EC CCN3-/-)。
接受 Ang II 输注显示主动脉根部增强、胸主动脉扩张以及血压升高
从机制上讲,我们最初的大量 RNAseq 研究表明,主动脉壁破坏的严重性。
CCN3 扰乱血管连接并导致参与信号通路的异常激活
我们随后的体内和体外进一步研究支持 CCN3 继发的关键因素。
缺乏(内皮屏障破坏、炎症、活性氧(ROS))会导致内皮细胞
这些观察结果提供了 TAAD 的功能障碍并在 TAAD 的发展和进展中发挥关键作用。
本申请的中心假设的基础:CCN3 作为关键的生理调节因子
本提案中的研究将维持内皮功能对于预防 TAAD 至关重要。
严格地解决这一假设将充分表征内皮 CCN3 在缓解 TAAD 中的作用。
将研究 CCN3 缺乏如何导致内皮功能障碍的机制基础。
这些研究将阐明CCN3在控制内皮功能中的作用及其机制
其促进内皮屏障完整性和限制炎症能力的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zhiyong Lin其他文献
Zhiyong Lin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zhiyong Lin', 18)}}的其他基金
Matricellular protein CCN3 in vascular homeostasis
基质细胞蛋白 CCN3 在血管稳态中的作用
- 批准号:
10662518 - 财政年份:2022
- 资助金额:
$ 67.78万 - 项目类别:
Deciphering the regulatory role of matricelluar protein CCN3 in functional collateral blood flow
解读基质细胞蛋白CCN3在功能性侧支血流中的调节作用
- 批准号:
10594955 - 财政年份:2020
- 资助金额:
$ 67.78万 - 项目类别:
Deciphering the regulatory role of matricelluar protein CCN3 in functional collateral blood flow
解读基质细胞蛋白CCN3在功能性侧支血流中的调节作用
- 批准号:
10371083 - 财政年份:2020
- 资助金额:
$ 67.78万 - 项目类别:
Role of Protein Phosphatase 2A in Aortic Aneurysm
蛋白磷酸酶 2A 在主动脉瘤中的作用
- 批准号:
10317079 - 财政年份:2019
- 资助金额:
$ 67.78万 - 项目类别:
KLF15 and circadian regulation of alcohol-induced liver injury
KLF15 与酒精性肝损伤的昼夜节律调节
- 批准号:
9212759 - 财政年份:2014
- 资助金额:
$ 67.78万 - 项目类别:
KLF15 and circadian regulation of alcohol-induced liver injury
KLF15 与酒精性肝损伤的昼夜节律调节
- 批准号:
9000080 - 财政年份:2014
- 资助金额:
$ 67.78万 - 项目类别:
KLF15 and circadian regulation of alcohol-induced liver injury
KLF15 与酒精性肝损伤的昼夜节律调节
- 批准号:
8576602 - 财政年份:2014
- 资助金额:
$ 67.78万 - 项目类别:
相似国自然基金
PKCε-Rab11介导KCNQ1通道膜蛋白下调促进血管紧张素II诱导的心肌肥厚致心律失常的机制研究
- 批准号:82204397
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
血管紧张素II活化的钙振荡在TBI后PSH相关的神经功能损害中的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
血管紧张素II2型受体在血管损伤中抑制周围脂肪组织功能失调的作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
LncRNA XIST通过micRNA-144-3p靶向Nrf2调控血管紧张素II引起心肌损伤的机制
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
血管紧张素II调控ATF3诱导铁死亡促进心梗后心室重构的机制研究
- 批准号:82000249
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
相似海外基金
REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary Hypertension
REVAMP-PH:重新利用缬沙坦可以预防肺动脉高压
- 批准号:
10642368 - 财政年份:2023
- 资助金额:
$ 67.78万 - 项目类别:
Endothelial Piezo1 channel and cerebral blood flow control
内皮Piezo1通道与脑血流控制
- 批准号:
10719633 - 财政年份:2023
- 资助金额:
$ 67.78万 - 项目类别:
Matricellular protein CCN3 in vascular homeostasis
基质细胞蛋白 CCN3 在血管稳态中的作用
- 批准号:
10662518 - 财政年份:2022
- 资助金额:
$ 67.78万 - 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Role of Hypertension in Favoring Osteoporosis
BCCMA:针对和抵抗不利于骨骼的条件(骨折遏制)的基础研究:高血压在促进骨质疏松症中的作用
- 批准号:
10483572 - 财政年份:2022
- 资助金额:
$ 67.78万 - 项目类别:
Sex disparities in aldosterone-dependent renal Na+ transport and blood pressure control
醛固酮依赖性肾钠转运和血压控制的性别差异
- 批准号:
10461199 - 财政年份:2021
- 资助金额:
$ 67.78万 - 项目类别: